English
Home > Products > 2136287-62-0

China 2136287-62-0 Factory

Our goal will be to offer premium quality items at competitive price ranges, and top-notch support to consumers around the planet. We are ISO9001, CE, and GS certified and strictly adhere to their high quality specifications for 2136287-62-0,CAS NO 2136287-62-0,Baloxavir Marboxil intermediate,Baloxavir Marboxil advance intermediate,7-(benzyloxy)-3,4,12,12a-tetrahydro-1H, Only for accomplish the good-quality product to meet customer's demand, all of our products have been strictly inspected before shipment.
2136287-62-0, We have a dedicated and aggressive sales team, and many branches, catering to our customers. We are looking for long-term business partnerships, and ensure our suppliers that they will definitely benefit in both short and long run.

Related Products

Hot Products

  • 4-Sulfonamide-phenylhydrazine hydrochloride

    4-Sulfonamide-phenylhydrazine hydrochloride

    Product Name:4-Sulfonamide-phenylhydrazine hydrochloride
    Molecular Formula:C6H10ClN3O2S
    Molecular Weight:223.68
    CAS Registry Number:27918-19-0
  • 2-(azetidin-3-ylidene)acetonitrile (hydrochloride)

    2-(azetidin-3-ylidene)acetonitrile (hydrochloride)

    Product Name:2-(azetidin-3-ylidene)acetonitrile (hydrochloride)
    Molecular Formula:C5H7ClN2
    Molecular Weight:130.58
    CAS Registry Number:1314910-43-4
  • 3-Hydroxyazetidine

    3-Hydroxyazetidine

    Product Name:3-Hydroxyazetidine
    Molecular Formula:C3H7NO
    Molecular Weight:73.09
    CAS Registry Number:45347-82-8
  • Ethyl 2-methylacetoacetate

    Ethyl 2-methylacetoacetate

    Product Name:Ethyl 2-methylacetoacetate
    Molecular Formula:C7H12O3
    Molecular Weight:144.17
    CAS Registry Number:609-14-3
  • YTTRIUM

    YTTRIUM

    Product Name:YTTRIUM
    Molecular Formula:Y
    Molecular Weight:88.91
    CAS Registry Number:7440-65-5
  • cerium trihydroxide

    cerium trihydroxide

    Product Name:cerium trihydroxide
    Molecular Formula:CeH3O3
    Molecular Weight:191.13802
    CAS Registry Number:15785-09-8
  • Related Blog
  • Reviews

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

CAS NO 2136287-62-0

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept